HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Limited new personal care/lingerie business IPO this fall.

This article was originally published in The Rose Sheet

Executive Summary

THE LIMITED PERSONAL CARE/LINGERIE COMPANY IPO PLANNED FOR THIS FALL, the company announced May 15 following the board of directors official approval of its restructuring plans. "By early fall," the company said, an initial public offering will spin off operations for The Limited's Bath & Body Works; Gryphon Development cosmetic division; Penhaligon's perfumeries; Victoria's Secret Stores and Catalogue and Cacique into a separate company that will be approximately 85% owned by The Limited. Philip Mallot, currently chief financial officer of The Limited's Structure business, has been appointed CFO for the yet unnamed personal care/lingerie company ("The Rose Sheet" May 1, In Brief). Tentative plans for the restructuring were announced March 28.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel